02256.HK
Abbisko Cayman Limited
HKSE · Healthcare · Biotechnology · CN
HKD 8.77
−1.79%Next report
Analyst consensus
- Next report date
- Mar 18, 2027
- EPS estimate
- -HKD 0.54
- Revenue estimate
- HKD 25.0M
Latest reported
- Last report date
- Aug 24, 2026
- EPS actual
- -HKD 0.35
- EPS estimate
- -HKD 0.39
- Revenue actual
- HKD 112.2M
- Revenue estimate
- HKD 57.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +11.8%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 18, 2027